Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
通过分析师的洞见，剖析4D分子治疗技术的各个层面。
In the preceding three months, 5 analysts have released ratings for 4D Molecular Therapeutics (NASDAQ:FDMT), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师发布了对4d分子治疗(纳斯达克:FDMT)的评级，提供了从看好到看淡的广泛观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $38.0, a high estimate of $40.00, and a low estimate of $36.00. Highlighting a 10.8% decrease, the current average has fallen from the previous average price target of $42.60.
分析师评估的12个月目标价揭示了进一步的见解，平均目标价为38.0美元，最高估值为40.00美元，最低估值为36.00美元。突显出平均目标价已经从先前的42.60美元下降了10.8%。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
The standing of 4D Molecular Therapeutics among financial experts...
通过深入探索最近...
登录免费看全文
登录/注册